ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EFTR eFFECTOR Therapeutics Inc

2.05
-0.11 (-5.09%)
May 04 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 311k02.01M867k675k000
Operating Income -12.4M-6.55M-7.88M-9.25M-8.72M-9.54M-7.86M-7.86M
Pre Tax Income 19.05M3.07M-6.92M-9.56M-9.26M-10.01M-8.36M-8.3M
Net Income 19.05M3.07M-6.92M-9.56M-9.26M-10.01M-8.36M-8.3M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -11.59M-7.23M-7.76M-9.21M-8.77M-9.55M-7.87M-7.86M
EBITDA -12.4M-6.54M-7.88M-9.23M-8.7M-9.51M-7.83M-7.83M
Year End December 30 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 01.43M3.55M0
Operating Income -2k-31.9M-32.4M-33.84M
Pre Tax Income -2k15.8M-22.67M-35.81M
Net Income -2k15.8M-22.67M-35.81M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) 00.171-0.242-0.308
EBIT -2k-30.86M-32.98M-33.87M
EBITDA -2k-31.87M-32.35M-33.73M

Your Recent History

Delayed Upgrade Clock